Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information (Tables)

v3.22.2
Supplemental Balance Sheet Information (Tables)
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

 

June 30,
2022

 

 

December 31,
2021

 

Accrued consulting

 

$

241,236

 

 

$

210,000

 

Accrued compensation

 

 

311,147

 

 

 

421,734

 

Deferred revenue

 

 

23,684

 

 

 

 

Accrued research and development

 

 

3,043,164

 

 

 

2,077,932

 

Accrued interest

 

 

 

 

 

968

 

Accrued other

 

 

10,630

 

 

 

5,127

 

Total accrued expenses and other current liabilities

 

$

3,629,861

 

 

$

2,715,761